Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Kearny Venture Partners
AddedFeb 19, 2024
UpdatedJun 28, 2026
Kearny Venture Partners

Kearny Venture Partners

Operating

Kearny Venture Partners: A US-based venture capital firm investing in healthcare companies.

Location
San Francisco, CA, US
Founded
2000
Firm
Compare
Portfolio
Employees
Website

Kearny Venture Partners is a healthcare-focused investment firm specializing in emerging healthcare products. The firm primarily invests in Series B, C, and post-IPO equity rounds, with occasional participation in Series A and D rounds. Their geographical focus appears to be the United States, targeting companies with significant market potential in areas of unmet medical needs.

Notable portfolio companies include Akebia Therapeutics, Cvrx, and ViewRay. Kearny Venture Partners believes in the power of innovative solutions in medicine and seeks to support entrepreneurs developing safe and effective products. The firm's investment philosophy centers on leveraging the increasing understanding of disease mechanisms to identify novel intervention opportunities in healthcare.

Kearny Venture Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments13
Current Portfolio Count3
Total Portfolio Exits0

Top Investment Stages

Post Ipo Equity3 (27.3%)
Series C3 (27.3%)
Series B2 (18.2%)
Series Unknown2 (18.2%)
Debt Financing1 (9.1%)

Stage Mix

Post Ipo Equity 27%Series C 27%Series B 18%Series Unknown 18%Debt Financing 9%

Concentration shown as share of disclosed investments by stage.

Recent Investments

ViewRay logo

ViewRay

Akebia Therapeutics logo

Akebia Therapeutics

Cvrx logo

Cvrx

Kearny Venture Partners - Similar Investment Firms

Kearny Jackson logo

Kearny Jackson

kearnyjackson.com

Key Venture Partners logo

Key Venture Partners

Venture Investors logo

Venture Investors

U.S. Venture Partners logo

U.S. Venture Partners

usvp.com

Kepha Partners logo

Kepha Partners

kephapartners.com

Kleiner Perkins Caufield & Byers logo

Kleiner Perkins Caufield & Byers

kleinerperkins.com

McKesson Ventures logo

McKesson Ventures

Visionary Venture Fund logo

Visionary Venture Fund

visionaryvc.com

Latterell Venture Partners logo

Latterell Venture Partners

lvpcapital.com

Kaiser Permanente Ventures logo

Kaiser Permanente Ventures

kpventures.com

NeuroVentures Capital logo

NeuroVentures Capital

neuroventures.com

Boutique Venture Partners logo

Boutique Venture Partners

boutiquevc.com

Kayon Partners logo

Kayon Partners

kayonpartners.com

Bioventures Investors logo

Bioventures Investors

Windamere Venture Partners logo

Windamere Venture Partners

Kearny Venture Partners - Classification

Also Known As
  • Kearny Venture Capital, L.L.C.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end